GENOM TAHRIRLASH TEXNOLOGIYALARINING TIBBIY BIOLOGIYADAGI ISTIQBOLLARI
Keywords:
genom tahrirlash, CRISPR-Cas9, gen terapiyasi, irsiy kasalliklarAbstract
Ushbu maqolada genom tahrirlash texnologiyalarining tibbiy biologiyadagi ahamiyati va istiqbollari yoritilgan. Xususan, CRISPR-Cas9, TALEN va ZFN kabi zamonaviy usullarning ishlash mexanizmi hamda ularning irsiy kasalliklar va saratonni davolashdagi o‘rni tahlil qilingan. Shuningdek, individual tibbiyot rivojlanishidagi roli ko‘rib chiqilgan. Genom tahrirlashning afzalliklari bilan bir qatorda, uning xavfsizlik muammolari, noaniq genetik o‘zgarishlar ehtimoli va etik jihatlari ham muhokama etilgan. Tadqiqot natijalari ushbu texnologiyalarning kelajakda tibbiyotda keng qo‘llanilish imkoniyatlari mavjudligini ko‘rsatadi.References
1. Doudna J.A., Charpentier E. The new frontier of genome engineering with CRISPR-Cas9 // Science, 2014.
2. Cox D.B.T., Platt R.J., Zhang F. Therapeutic genome editing: prospects and challenges // Nature Medicine, 2015.
3. Carroll D. Genome engineering: past, present and future // Genetics, 2017.
4. Jinek M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity // Science, 2012.
5. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering // Cell, 2014.
1. Anzalone A.V. et al. Search-and-replace genome editing without double-strand breaks // Nature, 2019.
2. Doudna J.A. The promise and challenge of therapeutic genome editing // Nature, 2020.
3. Frangoul H. et al. CRISPR-Cas9 gene editing for sickle cell disease // New England Journal of Medicine, 2021.
4. Gillmore J.D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis // NEJM, 2021.
5. Paix A. et al. Precision genome editing using CRISPR technology // Annual Review of Genetics, 2021.
6. Ledford H. CRISPR gene editing shows promise against cancer // Nature, 2022.
7. Musunuru K. et al. In vivo CRISPR base editing of PCSK9 // Nature, 2023.
8. Doudna J.A. CRISPR therapies: progress and challenges // Science, 2023.